Abstract
The assessment of the athlete for sports participation remains important as a means to identify those individuals who may have an underlying cardiovascular anomaly that increases their risk for sudden cardiac arrest during practice or competition. The basic requirements for assessment include a thorough history and physical examination. The use of a routine screening electrocardiogram (ECG) and/or echocardiogram remains controversial, though the specificity of ECG screening continues to improve as criteria specific to the athletic population are developed and tested. Given its versatility for screening for multiple structural and electrical cardiovascular anomalies, the ECG is often the first ancillary test performed when concern arises during the initial evaluation. Echocardiography, exercise stress testing, ambulatory ECG monitoring, and chest radiography provide additional diagnostic information when concerning historical or examination findings are uncovered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Antzelevitch C, Brugada P et al (2005) Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111(5):659–670
Baggish AL, Hutter AM et al (2010) Cardiovascular screening in college athletes with and without electrocardiography: a cross-sectional study. Ann Intern Med 152:269–275
Corrado D, Pelliccia A et al (2005) Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 26:516–524
Corrado D, Basso C et al (2006) Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296:1593–1601
Corrado D, Pelliccia A et al (2010) Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 31(2):243–259
Drezner JA, Asif IM et al (2012) Accuracy of ECG interpretation in competitive athletes: the impact of using standardised ECG criteria. Br J Sports Med 46(5):335–340
Drezner JA, Fischbach P et al (2013) Normal electrocardiographic findings: recognising physiological adaptations in athletes. Br J Sports Med 47(3):125–136
Drezner JA, Ackerman MJ et al (2013) Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease. Br J Sports Med 47(3):153–167
Drezner JA, Ashley E et al (2013) Abnormal electrocardiographic findings in athletes: recognising changes suggestive of cardiomyopathy. Br J Sports Med 47(3):137–152
Eckart RE, Shry EA et al (2011) Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 58(12):1254–1261
Gollob MH, Redpath CJ et al (2011) The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol 57(7):802–812
Glover DW, Glover DW et al (2007) Evolution in the process of screening United States high school student-athletes for cardiovascular disease. Am J Cardiol 100(11):1709–1712
Harmon KG, Asif IM et al (2011) Incidence of sudden cardiac death in national collegiate athletic association athletes. Circulation 123(15):1594–1600
Hill AC, Miyake CY et al (2011) Accuracy of interpretation of preparticipation screening electrocardiograms. J Pediatr 159:783–788
Ljungqvist A, Jenoure P et al (2009) The International Olympic Committee (IOC) consensus statement on periodic health evaluation of elite athletes. http://www.olympic.org/Documents/Reports/EN/en_report_1448.pdf
Loeys BL, Dietz HC et al (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47(7):476–485
Madsen NL, Drezner JA et al (2013) Sudden cardiac death screening in adolescent athletes: an evaluation of compliance with national guidelines. Br J Sports Med 47(3):172–177
Magalski A, McCoy M et al (2011) Cardiovascular screening with electrocardiography and echocardiography in collegiate athletes. Am J Med 124(6):511–518
Malhotra R, West JJ et al (2011) Cost and yield of adding electrocardiography to history and physical in screening division I intercollegiate athletes: a 5-year experience. Heart Rhythm 8(5):721–727
Marcus FI, McKenna WJ et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121(13):1533–1541
Maron BJ, Pelliccia A et al (1995) Cardiac disease in young trained athletes: insights into methods for distinguishing athlete’s heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 91:1596–1601
Maron BJ, Shirani J et al (1996) Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 276:199–204
Maron BJ, Gohman TE et al (1998) Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol 32(7):1881–1884
Maron BJ, Thompson PD et al (2007) Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 115(12):1643–1655
Maron BJ, Doerer JJ et al (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119(8):1085–1092
Maron BJ, Haas TS et al (2009) Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 104(2):276–280
Papadakis M, Whyte G et al (2008) Preparticipation screening for cardiovascular abnormalities in young competitive athletes. BMJ 337:a1596
Pelliccia A, Di Paolo FM et al (2006) Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 27:2196–2200
Pelliccia A, Culasso F et al (2007) Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. Eur Heart J 28:2006–2010
Priori SG, Napolitano C et al (2002) Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106(1):69–74
Schwartz PJ, Crotti L (2011) QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 124(20):2181–2184
Skinner JR, Crawford J et al (2011) Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm 8(3):412–419
Steinvil A, Chundadze T et al (2011) Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol 57(11):1291–1296
Uberoi A, Stein R et al (2011) Interpretation of the electrocardiogram of young athletes. Circulation 124(6):746–757
Weiner RB, Hutter AM et al (2011) Performance of the 2010 European Society of Cardiology criteria for ECG interpretation in athletes. Heart 97(19):1573–1577
Wheeler MT, Heidenreich PA et al (2010) Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes. Ann Intern Med 152:276–286
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this entry
Cite this entry
Kovach, J., Berger, S. (2014). Assessment of the Athlete for Sports Participation. In: Da Cruz, E., Ivy, D., Jaggers, J. (eds) Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. Springer, London. https://doi.org/10.1007/978-1-4471-4619-3_217
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4619-3_217
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4618-6
Online ISBN: 978-1-4471-4619-3
eBook Packages: MedicineReference Module Medicine